Global Health Care Sector

On June 20, the Ishares Nasdaq Biotech ETF broke out of a 10-month consolidation on 4x the average daily volume. Since, the ETF has constructively pulled back in light volume to its 21-DMA before bouncing back into new highs again. Our four biotech buy recommendations include Bioverativ , Celgene , Regeneron , and Vertex